Trials / Active Not Recruiting
Active Not RecruitingNCT06685835
A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS)
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa - The CEDAR Study
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 214 (actual)
- Sponsor
- Insmed Incorporated · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of the study is to evaluate the effect of brensocatib compared with placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brensocatib | Film-coated Oral tablet |
| DRUG | Placebo | Film-coated Oral tablet |
Timeline
- Start date
- 2024-12-16
- Primary completion
- 2026-02-12
- Completion
- 2026-11-17
- First posted
- 2024-11-13
- Last updated
- 2026-03-06
Locations
72 sites across 10 countries: United States, Australia, Bulgaria, Canada, France, Germany, Greece, Netherlands, Poland, Spain
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06685835. Inclusion in this directory is not an endorsement.